These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Mucins, gut microbiota, and postbiotics role in colorectal cancer. Pothuraju R; Chaudhary S; Rachagani S; Kaur S; Roy HK; Bouvet M; Batra SK Gut Microbes; 2021; 13(1):1974795. PubMed ID: 34586012 [TBL] [Abstract][Full Text] [Related]
26. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343 [TBL] [Abstract][Full Text] [Related]
27. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts. da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153 [TBL] [Abstract][Full Text] [Related]
28. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease. Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710 [TBL] [Abstract][Full Text] [Related]
29. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. Distrutti E; Monaldi L; Ricci P; Fiorucci S World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286 [TBL] [Abstract][Full Text] [Related]
30. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170 [TBL] [Abstract][Full Text] [Related]
31. Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review. Baldi S; Mundula T; Nannini G; Amedei A World J Gastroenterol; 2021 Oct; 27(39):6715-6732. PubMed ID: 34754163 [TBL] [Abstract][Full Text] [Related]
32. Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management? Mehmood K; Moin A; Hussain T; Rizvi SMD; Gowda DV; Shakil S; Kamal MA Folia Microbiol (Praha); 2021 Dec; 66(6):897-916. PubMed ID: 34699042 [TBL] [Abstract][Full Text] [Related]
33. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients. Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515 [TBL] [Abstract][Full Text] [Related]
34. Gut Microbiota and Complications of Type-2 Diabetes. Iatcu CO; Steen A; Covasa M Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044 [TBL] [Abstract][Full Text] [Related]
35. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review. Chlebicz-Wójcik A; Śliżewska K Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439821 [TBL] [Abstract][Full Text] [Related]
36. Probiotics, prebiotics, and synbiotics regulate the intestinal microbiota differentially and restore the relative abundance of specific gut microorganisms. Li C; Niu Z; Zou M; Liu S; Wang M; Gu X; Lu H; Tian H; Jha R J Dairy Sci; 2020 Jul; 103(7):5816-5829. PubMed ID: 32418689 [TBL] [Abstract][Full Text] [Related]
37. Role of diet and gut microbiota on colorectal cancer immunomodulation. De Almeida CV; de Camargo MR; Russo E; Amedei A World J Gastroenterol; 2019 Jan; 25(2):151-162. PubMed ID: 30670906 [TBL] [Abstract][Full Text] [Related]
38. Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment. Shi J; Wang Y; Cheng L; Wang J; Raghavan V Crit Rev Food Sci Nutr; 2024; 64(17):5984-6000. PubMed ID: 36576159 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high-risk populations: A systematic review and meta-analysis of randomized controlled trials. Kan HX; Cao Y; Ma Y; Zhang YL; Wang J; Li J; Li JN J Dig Dis; 2024 Jan; 25(1):14-26. PubMed ID: 38126945 [TBL] [Abstract][Full Text] [Related]
40. Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota. Flaig B; Garza R; Singh B; Hamamah S; Covasa M Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]